HUM · Humana Inc.

413.16

USD

-19.04 (-4.405%)

16/10/2026 04:10:00 PM

Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

US$51.86B

N/A

EV/EBITDA

N/A

DIV Yield

N/A

Payout Ratio

N/A

MQV Rating

3Neutral

As at 16/10/2026 04:10:00 PM

Price Chart

Description

Humana Inc. engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which refer to as state-based contracts. The CenterWell segment represents payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

All-Companies
All-Consensus
HALO 500
HALO All
HALO Momentum
Hammer Bullish
Near Resistance
Near Resistance (Realtime)
Recent Price upgrade
Volume Spike

Key Fundamentals

EPS 3 yr Growth

N/A

EBITDA Margin

N/A

Operating Cashflow

N/A

Free Cash Flow Return

N/A

ROIC

N/A

Interest Coverage

N/A

Quick Ratio

N/A

Performance

52 weeks range

N/A

Trade Value (12mth)

N/A

1 week

1 month

YTD

1 year

All time high

N/A

Additional Data

Shares Outstanding (Fully Diluted)

N/A

HALO Sector

Other Finance

Next Company Report Date

N/A

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

N/A

Short Sell (% of issue)

Consensus

Unlock full consensus

Consensus score

/10

Recommendation

Buy

Target price

Deviation

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Neutral

Garp

Very Weak

Mqv Small

Neutral

Momentum

Price

Strong

Earnings

Neutral

Growth

Earnings

Weak

Dividends

Neutral

Quality

Capital Efficiency

Neutral

Balance Sheet

Neutral

Valuation

Unlock full dataset

Value

Consensus

Yield

News & Announcements

Date	Event
13 October 26EDG
09 October 26EDG
01 September 26EDG
30 July 26EDG
29 July 26EDG

Key Stakeholders

Name	Title
OrbiMed Advisors Private Equity	Subsidiary
Joseph C Ventura	Individual
David E. Dintenfass	Individual
Frank A. D'Amelio	Individual
Kurt J. Hilzinger	Individual